Results 101 to 110 of about 38,429 (312)

Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial

Clinical Pharmacology &Therapeutics, EarlyView.
Antiangiogenic therapy with bevacizumab improves outcomes in ovarian cancer but induces hypertension, leading to major adverse cardiovascular events (MACE). While calcium channel blockers (CCBs) and angiotensin‐converting enzyme inhibitors (ACEi) are recommended for managing bevacizumab‐associated hypertension, their impacts on cancer progression and ...
Floriane Jochum, Élise Dumas, Joe‐Elie Salem, Stéphane Ederhy, Anne‐Sophie Hamy, Lise Lecointre, Enora Laas, Fabien Reyal, Fabrice Lecuru, Cherif Akladios, Paul Gougis   +10 more
wiley   +1 more source

Spinal cord stimulation in critical limb ischemia [PDF]

, 2001
G.H. Spincemaille
openalex   +1 more source

Pathogenesis and potential therapeutic targets of trichorhinophalangeal syndrome; lessons obtained from animal studies

Developmental Dynamics, EarlyView.
Abstract Trichorhinophalangeal syndrome (TRPS) is a rare genetic disease inherited in an autosomal dominant manner. It occurs in 1 in 100,000 people globally and is caused by several types of mutations of the TRPS1 gene. Since the first human patient was reported in 1966, typical and atypical pathologies, disease courses, and treatment case ...
Naoya Saeki, Rinna Kanai, Sayuri Tatsuta, Shinichi Kawaguchi, Masatsune Itoh, Shinsuke Ohba, Makoto Abe   +6 more
wiley   +1 more source

Outcome and influence of age after infrainguinal revascularization in critical limb ischemia [PDF]

, 2002
Zbigniew Zdanowski
openalex   +1 more source

Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia

, 1997
John J. Castronuovo, Habtu M. Adera, Janice M. Smiell, Ray M. Price   +3 more
openalex   +1 more source

Prognostic impact of SCAI shock severity classes in AMI‐related cardiogenic shock: A sub‐study of the ECLS‐SHOCK Trial

ESC Heart Failure, EarlyView.
Patients with AMI‐CS (lactate >3 mmol/L) enrolled in the multicentre, randomized ECLS‐SHOCK trial were included. From a total of 417 patients, 51.6% (n = 215), 13.4% (n = 56) and 35.0% (n = 146) presented in SCAI Stages C, D and E, respectively. SCAI stages were associated with the risk of 30 day all‐cause mortality, with rates of renal replacement ...
Janine Pöss, Jacob Jentzer, Steffen Desch, Hans‐Josef Feistritzer, Anne Freund, Michelle Roßberg, Christian Jung, Taoufik Ouarrak, Steffen Schneider, Ibrahim Akin, Tienush Rassaf, Tharusan Thevathasan, Uwe Zeymer, Holger Thiele   +13 more
wiley   +1 more source

Angiogenic Gene Therapy for Experimental Critical Limb Ischemia [PDF]

, 2002
Ichiro Masaki, Yoshikazu Yonemitsu, Akihisa Yamashita, Shihoko Sata, Mitsugu Tanii, Kimihiro Komori, Kazunori Nakagawa, Xiaogang Hou, Yoshiyuki Nagai, Mamoru Hasegawa, Keizō Sugimachi, Katsuo Sueishi   +11 more
openalex   +1 more source

Impact of comorbidity burden on outcome in patients with cardiogenic shock: A Cardiogenic Shock Working Group analysis

European Journal of Heart Failure, EarlyView.
Impact of comorbidity burden on outcome in patients with cardiogenic shock. AMI, acute myocardial infarction; CAD, coronary artery disease; CI, confidence interval; CKD, chronic kidney disease; COMRI‐CS; Comorbidity Risk Index for Cardiogenic Shock; COPD, chronic obstructive pulmonary disease; CS, cardiogenic shock; CSWG, Cardiogenic Shock Working ...
Jonas Sundermeyer, Song Li, Van‐Khue Ton, Rachna Kataria, Elric Zweck, Kevin John, Manreet K. Kanwar, Jaime Hernandez‐Montfort, Shashank S. Sinha, A. Reshad Garan, Jacob Abraham, Vanessa Blumer, Ajar Kochar, Karthikeyan Ranganathan, Gavin W. Hickey, Mohit Pahuja, Scott Lundgren, Sandeep Nathan, Esther Vorovich, Shelley Hall, Wissam Khalife, Andrew Schwartzman, Ju Kim, Oleg Alec Vishnevsky, Justin Fried, Maryjane Farr, Joseph Mishkin, I‐Hui Chang, Onyedika Ilonze, Alexandra Arias, Jun Nakata, Jeffrey Marbach, Hiram Bezerra, Ann Gage, Joyce Wald, Sunu Thomas, Faisal Rahman, Amirali Masoumi, Aasim Afzal, Salman Gohar, Rachel Goodman, Karol D. Walec, Peter Natov, Borui Li, Paavni Sangal, Qiuyue Kong, Peter Zazzali, Neil M. Harwani, Saraschandra Vallabhajosyula, Arvind Bhimaraj, Claudius Mahr, Daniel Burkhoff, Navin K. Kapur   +52 more
wiley   +1 more source

Red blood cell endothelial nitric oxide synthase: A major player in regulating cardiovascular health

British Journal of Pharmacology, EarlyView., 2023
Abstract Red blood cells (RBCs) have traditionally been seen as simple carriers of gases and nutrients in the body. One important non‐canonical function of RBCs in the cardiovascular system is the regulation of nitric oxide (NO) metabolism. It has been shown that RBCs can scavenge NO, transport NO metabolites and produce NO in hypoxic conditions ...
Anthea LoBue, Sophia K. Heuser, Marla Lindemann, Junjie Li, Masudur Rahman, Malte Kelm, Johannes Stegbauer, Miriam M. Cortese‐Krott   +7 more
wiley   +1 more source

Is revascularization and limb salvage always the best treatment for critical limb ischemia? [PDF]

, 2003
Mark R. Nehler, William R. Hiatt, Lloyd M. Taylor   +2 more
openalex   +1 more source